Endologix to Present at Three Upcoming Conferences
November 03 2009 - 4:05PM
PR Newswire (US)
IRVINE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Endologix, Inc.
(NASDAQ: ELGX), developer of minimally invasive treatments for
aortic disorders, announced today that John McDermott, President
and Chief Executive Officer, is scheduled to present at three
upcoming investor conferences. The first presentation will be at
the Canaccord Adams 3rd Annual Cardiovascular Conference at the
Nikko Hotel in San Francisco, CA. Event: Canaccord Adams 3rd Annual
Cardiovascular Conference Date: Tuesday, November 10, 2009 Time:
11:00 a.m. PT The second presentation will be at the Lazard Capital
Markets 6th Annual Healthcare Conference at the St. Regis Hotel in
New York City. Event: Lazard Capital Markets 6th Annual Healthcare
Conference Date: Wednesday, November 18, 2009 Time: 10:00 a.m. ET
The third presentation will be at the Piper Jaffray 21st Annual
Health Care Conference at the New York Palace Hotel in New York
City. Event: Piper Jaffray 21st Annual Health Care Conference Date:
Tuesday, December 1, 2009 Time: 2:30 p.m. ET An audio Web cast of
the Company's presentations will be available by visiting the
investor relations section of Endologix's Web site at
http://www.endologix.com/. A replay of the presentations will be
available for 30 days. About Endologix, Inc. Endologix, Inc.
develops and manufactures minimally invasive treatments for aortic
disorders. The Company's flagship product is the Powerlink® System,
which is an endovascular stent graft for the treatment of abdominal
aortic aneurysms (AAA). AAA is a weakening of the wall of the
aorta, the largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture.
Additional information can be found on Endologix's Web site at
http://www.endologix.com/ COMPANY CONTACT: INVESTOR CONTACTS:
---------------- ------------------ Endologix, Inc. The Ruth Group
John McDermott, CEO Nick Laudico (646) 536-7030 (949) 595-7200 Zack
Kubow (646) 536-7020 http://www.endologix.com/ DATASOURCE:
Endologix, Inc. CONTACT: John McDermott, CEO, Endologix, Inc.,
+1-949-595-7200; or for Investors, Nick Laudico, +1-646-536-7030 or
Zack Kubow, +1-646-536-7020, both of The Ruth Group Web Site:
http://www.endologix.com/
Copyright